Fulcrum Therapeutics Inc (FULC) stock is up 52.84% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives FULC stock a score of 67 out of a possible 100.
That rank is primarily influenced by a fundamental score of 95. In addition to the average rating from Wall Street analysts, FULC stock has a mean target price of $36.33. This means analysts expect the stock to increase 98.43% over the next 12 months. FULC's rank also includes a long-term technical score of 54. The short-term technical score for FULC is 53.
FULC has an Overall Score of 67. Find out what this means to you and get the rest of the rankings on FULC!
Fulcrum Therapeutics Inc (FULC) stock is up 0.38% while the S&P 500 is up 0.07% as of 10:39 AM on Friday, Nov 12. FULC is up $0.03 from the previous closing price of $18.28 on volume of 39,672 shares. Over the past year the S&P 500 is higher by 31.53% while FULC is up 52.84%. FULC lost -$2.35 per share in the over the last 12 months.
Click Here to get the full Stock Report for Fulcrum Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
